These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3022888)

  • 21. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topography and characteristics of specific binding sites for non-opioid gamma-type endorphins in the rat brain as studied by autoradiography with [35S]Met-desenkephalin-gamma-endorphin.
    Ronken E; Wiegant VM; Kaspersen FM; van Nispen JW; de Boer T; Bruning HW; Rust CJ; Tonnaer JA
    Brain Res; 1993 Jun; 615(1):63-70. PubMed ID: 8395956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple opioid receptor systems in brain and spinal cord: Part I.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Jun; 1(2):171-99. PubMed ID: 6152613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).
    Gairin JE; Mazarguil H; Alvinerie P; Botanch C; Cros J; Meunier JC
    Br J Pharmacol; 1988 Dec; 95(4):1023-30. PubMed ID: 2905908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. Identification of binding site subunit.
    Howard AD; de La Baume S; Gioannini TL; Hiller JM; Simon EJ
    J Biol Chem; 1985 Sep; 260(19):10833-9. PubMed ID: 2993292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate receptor binding affinities of some D-amino acid substituted beta-casomorphin analogs.
    Liebmann C; Szücs M; Neubert K; Hartrodt B; Arold H; Barth A
    Peptides; 1986; 7(2):195-9. PubMed ID: 3016678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography.
    Tempel A; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4308-12. PubMed ID: 3035579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postnatal development of multiple opioid receptors in rat brain.
    Kornblum HI; Hurlbut DE; Leslie FM
    Brain Res; 1987 Dec; 465(1-2):21-41. PubMed ID: 2830947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity.
    Katz Y; Weizman A; Pick CG; Pasternak GW; Liu L; Fonia O; Gavish M
    Brain Res; 1994 May; 646(2):235-41. PubMed ID: 8069669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors.
    Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1985 Jul; 225(1238):27-40. PubMed ID: 2863824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
    Giordano AL; Nock B; Cicero TJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):536-40. PubMed ID: 2173747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal lead exposure alters the development of delta- but not mu-opioid receptors in rat brain.
    McDowell J; Kitchen I
    Br J Pharmacol; 1988 Jul; 94(3):933-7. PubMed ID: 2846111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
    Bidlack JM
    NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.